{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T01:49:23Z","timestamp":1795052963972,"version":"4.10.2"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:p>This pooled analysis compared the risk of venous thromboembolism (VTE) associated with combined oral contraceptives (COCs) containing estradiol (E2) valerate\u2013dienogest with those containing ethinyl E2\u2013levonorgestrel. Data were retrieved from two large, prospective, observational cohort studies. Propensity score subclassification was applied to balance baseline parameters between the COC user cohorts. Crude and adjusted hazard ratios (HRs) were calculated based on the extended Cox model. The pooled data set included 11,616 E2 valerate\u2013dienogest users and 18,681 ethinyl E2\u2013levonorgestrel users, contributing 17,932 and 29,140 women-years of observation, respectively. A significantly decreased VTE risk in E2 valerate\u2013dienogest COCs compared with ethinyl E2\u2013levonorgestrel COCs was observed (propensity score\u2013stratified HR 0.46, 95% CI, 0.22\u20130.98). This pooled analysis expands data from a previous postauthorization safety study and provides valuable real-world safety information on the relative safety of current COCs.<\/jats:p>","DOI":"10.1097\/aog.0000000000005509","type":"journal-article","created":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T22:00:25Z","timestamp":1705442425000},"page":"431-434","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":29,"title":["Venous Thromboembolic Risk of Estradiol Valerate\u2013Dienogest Compared with Ethinyl Estradiol\u2013Levonorgestrel Combined Oral Contraceptives"],"prefix":"10.1097","volume":"143","author":[{"given":"Anja","family":"Bauerfeind","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"von Stockum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Boehnke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaas","family":"Heinemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,1,16]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.fertnstert.2016.09.027","article-title":"Combined hormonal contraception and the risk of venous thromboembolism: a guideline","volume":"107","year":"2017","journal-title":"Fertil Steril"},{"key":"R2-20250502","first-page":"e757","article-title":"Half a century of the oral contraceptive pill: historical review and view to the future","volume":"58","author":"Liao","year":"2012","journal-title":"Can Fam Physician"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3109\/09513590.2012.662547","article-title":"An overview of the development of combined oral contraceptives containing estradiol: focus on estradiol valerate\/dienogest","volume":"28","author":"Fruzzetti","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1089\/jwh.2013.4320","article-title":"Efficacy and safety of a combined oral contraceptive containing estradiol valerate\/dienogest: results from a clinical study conducted in North America","volume":"23","author":"Nelson","year":"2014","journal-title":"J Womens Health"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.contraception.2016.06.010","article-title":"Impact of estrogen type on cardiovascular safety of combined oral contraceptives","volume":"94","author":"Dinger","year":"2016","journal-title":"Contraception"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/13625187.2019.1629412","article-title":"Unintended pregnancy rates differ according to combined oral contraceptive \u2013 results from the INAS-SCORE study","volume":"24","author":"Barnett","year":"2019","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/ije\/17.4.955","article-title":"A strengthening programme for weak associations","volume":"17","author":"Rothman","year":"1988","journal-title":"Int J Epidemiol"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15761\/FWH.1000178","article-title":"Combined oral contraceptives containing dienogest and estradiol valerate may carry a lower risk of venous and arterial thromboembolism compared to conventional preparations: results from the extended INAS-SCORE study","volume":"5","author":"Dinger","year":"2020","journal-title":"Front Womens Health"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/22840265211019546","article-title":"Thromboembolic safety profile of low-dose estradiol (valerate) in combined hormonal preparations: implications for the development of new hormonal endometriosis and uterine fibroid therapies","volume":"13","author":"Barnett","year":"2021","journal-title":"J Endometriosis Pelvic Pain Disord"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000005509","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:02:21Z","timestamp":1746230541000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000005509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,16]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005509","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,16]]},"assertion":[{"value":"2023-09-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}